keep up with soaring prices of medications and medical instruments, doctors tell CNN.
European banks, fearing secondary US penalties, are reluctant to do business with Iranian companies even those not blacklisted b
y the US. Medical companies have had to resort to paying intermediaries exorbitant sums to secure ne
eded supplies, including imported medicines and medical instruments which have more than tripled in value du
ring Iran’s rapidly dropping currency, health professionals explain.Sanctions is the first problem in our country and in ou
r system. We can’t transfer the money and make the preparations for surgery. It’s a big problem for us,” says Dr. Mo
hammad Hassan Bani Asad, managing director of the Gandhi Hotel Hospital. “We have the procedures, but we don’t hav
e the instruments. It is very difficult for patients and maybe leads to death of some patients.”
Though most of Iran’s medicines are domestically manufactured, much of the primary materials, m
any of them imported, are in short supply. And while the state provides universal healthcare, so
me of the treatment needed for critical cases cannot be covered by state insurance.
Previous post: [ with foreign delegates attending the 2018 Imperial Spri ]